000 07761nam a22006495i 4500
001 978-3-030-80662-0
003 DE-He213
005 20250516160156.0
007 cr nn 008mamaa
008 241113s2024 sz | s |||| 0|eng d
020 _a9783030806620
_9978-3-030-80662-0
050 4 _aRC346-429.2
072 7 _aMJN
_2bicssc
072 7 _aMED056000
_2bisacsh
072 7 _aMKJ
_2thema
082 0 4 _a616.8
_223
245 1 4 _aThe Textbook of Nanoneuroscience and Nanoneurosurgery
_h[electronic resource] /
_cedited by Babak Kateb, John D. Heiss, John S. Yu, Ming Hsieh.
250 _a2nd ed. 2024.
264 1 _aCham :
_bSpringer Nature Switzerland :
_bImprint: Springer,
_c2024.
300 _aXVI, 849 p. 285 illus., 221 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _aFrom Nanotechnology to Nanoneuroscience/Nanoneurosurgery and Nanobioelectronics: A review of Milestones -- Nanoneurology and Nanoneurosurgery -- Nanopolymers and Nanoconjugates for Central Nervous System Theranostics -- Micelles and Liposomes: Lipid Nano-vehicles for Intracerebral Drug Delivery -- Peptide and Protein-Based Nanoparticles -- Endohedral Metallofullerenes, Iron Oxide Agents, and Gold Nanoparticles for Brain Imaging -- Carbon Nanoplatforms and Theranostics for Neurological Disorders -- Dendrimers -- Ligand-Based Targeting of therapeutics and Imaging Agents for Cancer -- Nano-assisted immune-Based Targeting in Cancer -- Directed Drug Convection Using Magnetic Nanoparticles as Therapeutic Carriers: Meeting the Challenge of Specific Brain Pharmacotherapeutics, Non-Ligand-Based Central Nervous System Targeting, Including Magnetic Focusing -- Intralesional and Intraparenchymal Convection-Enhanced Delivery of Nanoparticles -- Therapeutics delivery across the blood-brain barrier -- Nanomedicine Treatment Strategies That Exploit Unique Characteristics of Tumor Vasculature and Microenvironment -- Application of nanoplatforms Focused Ultrasounds Neuromodulation -- Nanosensors -- Implantable Infusion Pumps incorporating nanotechnology -- Application of Nanoplatforms for Intracerebral Neurotransmitter Recording -- State-of-art therapy for Neuronopathic Lysosomal Storage Diseases -- Nanotechnology for Cerebral Aneurysm Treatment -- Improving Treatment of Stroke through Nanotechnology -- Molecular Medical Devices for Nanoneurosurgery -- Nanoneuroscience for Epilepsy Management -- Application of Nanotechnology to Disease of Spine -- Nanoparticle-based Treatment and Imaging of Brain Tumors: Potential and Limitations -- Tumor-Targeted Nanodrugs for Treatment of Primary Brain Tumors -- Application of Nanotechnology in Diagnosis and Treatment of Brain metastasis -- Nanotechnology in Extra-Axial and Pituitary Tumors -- Using Nanoparticles in Diagnosis and Treatment of CNS infection -- Application of Nanotechnology in Movement Disorder -- Nanomedicine in Demyelinating Disease: Application to Diagnosis and Therapey in Multiple Sclerosis -- Application of Nanotechnology in Degenerative Disorders of the Brain -- Brain-Machine Interface and Rehabilitation -- Nanobioelectronics for non-invasive neural therapy -- In Vitro and In Vivo Techniques to Assess Neurotoxicity of Nanoparticles -- Nanorobotics for Neurosurgery -- Imaging and Tracking Therapeutic Cells with Nanoparticles -- Micro and Nanotechnology in Nerve Repair -- Nanotechnology: Applications to Pediatric Neurosurgery -- Food and Drug Administration Regulatory Framework for Nanodrugs and Nanodevices and the Combination -- Key policies issues and initiatives related to Nanoneurosurgery and Nanoneuroscience -- Application of Nanotechnology for Neurovascular Disorders -- Nanoneurosurgery and Radiotherapy -- Inorganic nano-systems for Nanoneuroscience -- Nanobioelectronics: Neuro-ophthalmology and Artificial Retina -- Application of a Conceptual Nanomedical Platform to Facilitate the Mapping of the Human Brain: Survey of Cognitive Functions and Implications -- Clinical trials in nanomedicine -- Nanostructured Boron and Gadolinium Compounds for BNCT (Boron-Neutron Capture Therapy) -- The use of microfluidic-based systems in Nanoneuroscience -- Application of 3D (bio)printing in Nanoneuroscience -- Brain Mapping in Glioma patients: from improvement of Clinical outcomes to critical implications in fundamental Neuroscience -- Nanomedicine and Genetherapy -- Nanoneuroscience for COVID19 Brain -- Application of Crisper and nanotechnology for Neurological Disorders -- NASA/National Labs Nanotechnology -- Acute Brain Injuries and Nanotechnology.
520 _aNanoneuroscience, nanoneurosurgery, and nanobioelectronics have revolutionized medicine and improved the prevention, diagnosis, and treatment of neurological disorders. The Textbook of Nanoneuroscience and Nanoneurosurgery, 2nd edition presents a state-of-the-art review of the field, providing current information about nanoplatforms and their use in neurosurgery, neurology, neuroscience, and neuroradiology. The text also reviews the latest regulatory guidelines that influence the translation of nanotechnological research from the laboratory to the clinic, as well as the most recent information on biodevices and pharmaceutical spinoffs. It highlights presidential and congressional initiatives and programs that may significantly impact the field in the near future. Chapters discuss the latest science and technologies-which are applied to diagnosis and treatment of neurological disorders-as well as regulatory issues that impact product development. This volume describes advances that have already been translated to the clinic or hold significant promise for future application in nanoneurosurgery, as well as their potential impact. A full-color text, the book contains contributions by more than 120 researchers, original and descriptive illustrations, and more than 3,000 references. Offering broad coverage of nanotechnological applications in diverse areas and addressing FDA regulation and healthcare policy,The Textbook of Nanoneuroscience and Nanoneurosurgery provides a foundation of ideas and methods for scientists and physicians to devise successful, less invasive procedures for future treatment of nervous system disorders.
541 _fUABC ;
_cPerpetuidad
650 0 _aNeurology .
650 0 _aPharmaceutical chemistry.
650 0 _aNeurosciences.
650 0 _aToxicology.
650 0 _aPharmacology.
650 0 _aMedicine
_xResearch.
650 0 _aBiology
_xResearch.
650 1 4 _aNeurology.
650 2 4 _aPharmaceutics.
650 2 4 _aNeuroscience.
650 2 4 _aToxicology.
650 2 4 _aPharmacology.
650 2 4 _aBiomedical Research.
700 1 _aKateb, Babak.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aHeiss, John D.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aYu, John S.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
700 1 _aHsieh, Ming.
_eeditor.
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
773 0 _tSpringer Nature eBook
776 0 8 _iPrinted edition:
_z9783030806613
776 0 8 _iPrinted edition:
_z9783030806637
776 0 8 _iPrinted edition:
_z9783031551925
856 4 0 _zLibro electrónico
_uhttp://libcon.rec.uabc.mx:2048/login?url=https://doi.org/10.1007/978-3-030-80662-0
912 _aZDB-2-SBL
912 _aZDB-2-SXB
942 _cLIBRO_ELEC
999 _c276815
_d276814